Iambic Therapeutics, Inc. Common Stock

IAM

Market cap $1.13B

23.81 USD

+4.90

25.91%

At close Updated Oct 16, 4:00 PM EDT

Pre-market

After hours

24.00

+0.19

0.8%

1 day

25.91%

5 days

47.43%

1 month

25.91%

3 months

25.91%

6 months

25.91%

Year to date

25.91%

1 year

25.91%

5 years

25.91%

10 years

25.91%

About: Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.

Healthcare Drug Manufacturers - General

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

Neutral

Seeking Alpha

1 day ago

U.S. IPO Weekly Recap: Biotechs City Therapeutics And Iambic Headline The Week's Pricings

Three IPOs and two SPACs priced this week, and two SPACs submitted filings. No IPOs are currently scheduled for the week ahead as the year's next mega IPO potentially comes into view. Street research is expected to for one company in the week ahead, and four lock-up periods will be expiring.

See News Rankings

Price charts implemented using Lightweight Charts™

Iambic Therapeutics, Inc. Common Stock IAM Market cap $1.13B

News

Iambic Therapeutics, Inc. Common Stock

IAM

Market cap $1.13B